Opthea Limited

Opthea Limitedverified

OPT

Price:

$4.21

Market Cap:

$628.43M

Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema DME, as well as a first in class VEGF C/D inhibitors for treatment with VEGF A inhibitors for the trea...[Read more]

Industry

Biotechnology

IPO Date

2020-10-16

Stock Exchange

NASDAQ

Ticker

OPT

The Current Ratio as of November 2024 (TTM) for Opthea Limited (OPT) is 2.94

According to Opthea Limited’s latest financial reports and current stock price. The company's current Current Ratio is 2.94. This represents a change of -60.32% compared to the average of 7.40 of the last 4 quarters.

Opthea Limited (OPT) Historical Current Ratio (quarterly & annually)

How has OPT Current Ratio performed in the past?

The mean historical Current Ratio of Opthea Limited over the last ten years is 13.20. The current 2.94 Current Ratio has changed 2.13% with respect to the historical average. Over the past ten years (40 quarters), OPT's Current Ratio was at its highest in in the June 2021 quarter at 44.46. The Current Ratio was at its lowest in in the March 2009 quarter at 0.

Quarterly (TTM)
Annual

Average

13.20

Median

8.20

Minimum

2.94

Maximum

44.46

Opthea Limited (OPT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Opthea Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 233.62%

Maximum Annual Current Ratio = 44.46

Minimum Annual Increase = -88.81%

Minimum Annual Current Ratio = 2.94

Quarterly (TTM)
Annual
YearCurrent RatioChange
20242.94-44.03%
20235.255.51%
20224.98-88.81%
202144.46198.88%
202014.8883.67%
20198.1041.69%
20185.72-79.35%
201727.68233.62%
20168.30-14.91%
20159.7572.43%

Opthea Limited (OPT) Average Current Ratio

How has OPT Current Ratio performed in the past?

The current Current Ratio of Opthea Limited (OPT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

4.39

5-year avg

14.50

10-year avg

13.20

Opthea Limited (OPT) Current Ratio vs. Peers

How is OPT’s Current Ratio compared to its peers?

Opthea Limited’s Current Ratio is less than Molecular Partners AG (14.58), less than MediciNova, Inc. (18.24), less than Anebulo Pharmaceuticals, Inc. (13.46), greater than Champions Oncology, Inc. (0.69), less than Cyteir Therapeutics, Inc. (21.89), less than Aerovate Therapeutics, Inc. (6.51), greater than Adagene Inc. (2.50), less than Acrivon Therapeutics, Inc. Common Stock (16.16), less than Rezolute, Inc. (13.39), less than AN2 Therapeutics, Inc. (10.61), less than Inhibrx Biosciences, Inc. (6.20), less than Mineralys Therapeutics, Inc. (11.20), less than Eliem Therapeutics, Inc. (60.41),

Build a custom stock screener for Opthea Limited (OPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Opthea Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Opthea Limited (OPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Opthea Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Opthea Limited's Current Ratio?

How is the Current Ratio calculated for Opthea Limited (OPT)?

What is the highest Current Ratio for Opthea Limited (OPT)?

What is the 3-year average Current Ratio for Opthea Limited (OPT)?

What is the 5-year average Current Ratio for Opthea Limited (OPT)?

How does the current Current Ratio for Opthea Limited (OPT) compare to its historical average?